Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
2.330
-0.090 (-3.72%)
At close: Oct 6, 2025, 4:00 PM EDT
2.370
+0.040 (1.72%)
After-hours: Oct 6, 2025, 4:17 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $660.95 million as of October 6, 2025. Its market cap has decreased by -19.01% in one year.
Market Cap
660.95M
Enterprise Value
323.63M
1-Year Change
-19.01%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $660.95M, a decrease of -64.43%. That is a compound annual growth rate of -21.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 686.48M | -3.26% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |